Who knew weight loss and wine could be frenemies? My journey with Ozempic started as a bid to shed pounds, but it ...

New studies in JACC highlight improvements in cardiac structure and function among CABG patients, as well as changes in ...

11月28日，中国国家药监局药品审评中心（CDE）官网最新公示，诺和诺德（Novo Nordisk）1类新药NNC0519-0130注射液获得临床试验默示许可，拟开发治疗2型糖尿病。根据诺和诺德公开资料，这是该公司在研的每周一次皮下注射的双靶点GIP/GLP-1受体激动剂，正在国际范围内开展2期临床，用于2型糖尿病和肥胖人群。本次为该产品首次在中国获批临床。

They've been dubbed 'game-changers' in the world of obesity, making the seemingly impossible, possible - significant weight ...

Federal and state health officials said Friday they are working to track down more information about a Salmonella outbreak ...

Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, ...

The CEO of the J.M. Smucker company has rejected the idea that Americans will stop indulging in snack foods despite campaigns ...

COMMENT: Weight-loss jabs have become so normalised in adult life, it won’t be long before children are pestering their ...

Here are the top industries and stocks that were impacted by the comments, actions and policies of President-elect Trump this week compiled by ...

Weight-loss drugs like Ozempic and Wegovy are gaining popularity as quick fixes for shedding pounds. Known as GLP-1 agonists, ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

Another day, another headline suggesting the new breed of diabetes and weight loss drugs offer hope for another chronic ...